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Abstract
Objective: The objective of this selective EBM review is to determine whether or not “Submental
deoxycholic acid injections reduce submental fat in adult patients enough to create a significant increase
in patient satisfaction”
Study Design: Review of 3 double blind, randomized control trials that were selected based on their
relevance to the clinical question.
Data Sources: All three peer-reviewed articles were found using PubMed and Cochrane Database. The
keywords “ATX-101”, “submental fat”, and “deoxycholic acid” were used.
Outcomes Measured: Satisfaction with appearance in association with face and chin evaluated by a
patient reported subject self-rating scale (PR-SSRS), a numeric scale with values from 0-6.
Results: All three trials recorded significant improvement in subject satisfaction compared to placebo
with a p-value <0.001. The REFINE-1 study showed had an NNT value of 2 with 82.8% of the treatment
group showing improvement compared to 31.0% of the placebo group. Ascher et al had an NNT of 3.
64.8% of the treatment group showed improvement with only 29.3% of the control group showing
improvement. Finally, Rzany et al reported an NNT of 3. The treatment group had an improvement rate
of 66.1% and the control group’s rate was only 28.7%.
Conclusion: Deoxycholic acid injections to the submental region resulted in a consistent improvement in
patients’ satisfaction with the appearance of their submental region. The NNT values are low proving
these injections to be effective in improving satisfaction.
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Introduction
Submental fat is considered by many to be aesthetically unappealing and its’ origin
is multifactorial; stemming from obesity, genetics, and aging. The increasing fullness underneath
the chin is almost always visible and can cause individuals significant social and psychological
stress. The presence of submental fullness is associated with all races, genders, and has an
increasing prevalence with age. Because of this trend, it is seen as a sign of aging and obesity.
Blunting of the cervicomental angle produces a less pronounced jawline. These issues can cause
a decrease in self-esteem.1-3
Currently there are a few options to decrease the fat below the chin. Surgical
interventions, such as platysmaplasty (neck lift) and liposuction procedures currently exist. In
addition there are also injectable treatments that are also available, however, these are currently
unregulated and can be unsafe.1-3 In a 2015 survey by the American Society for Dermatologic
Surgery 67% of the population reported to be extremely bothered by the excess fat under their
chin/neck4. In 2015 the number of neck lifts performed in the United States was 32, 695 per the
Interanational Society of Aesthetic Plastic Surgery. This does not include consultation visits and
post-procedure visits . There were 119,470 procedures of non-surgical fat removal but this was
not differentiated into body area. In addition, there were 1,805,895 injection procedures but
again, this was not differentiated by injection site5.
The exact cost for money spent on reduction of submental fat is not statistically available,
however, the American Society for Aesthetic Plastic Surgery reports that total expenditures for
surgical chin augmentation in 2012 was $26,623,143. This is not including the costs for
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liposuction and other non-surgical injectables. Overall in 2012 Americans spent over $10 billion
for cosmetic procedures in 2012.6
Deoxycholic acid is a substance that causes adipocytes to lyse by disrupting their
membrane. This method is seen to be much safer than surgical interventions that can lead to long
recovery times and increased rate of infections. The surgical procedures can also leave an
aesthetic deformity. The currently used injectables have no documented efficacy, so deoxycholic
acid has been proposed as a safe, effective way to reduce submental fat1,2,3.
Objective
The objective of this selective EBM review is to determine whether or not
“submental deoxycholic acid injections reduce submental fat in adult patients enough to create a
significant increase in patient satisfaction”
Methods
The population of patients used in the studies in this review was adults aged 18-65.
All of the adults were dissatisfied with the appearance of their submental region (0-3 on the
patient reported submental fat rating scale) and they all were rated moderate to severe submental
fat (2-3 on the clinician reported submental fat rating scale). All of the studies tested the efficacy
and the safety of deoxycholic acid injections into the submental region. Each individual injection
was 0.2mL with a max dose of 10mL per patient per treatment. Some of the studies included two
treatment groups, one with a concentration of 1.0mg/cm2, and another with a concentration of
2.0mg/cm2. A 1.0cm x 1.0cm grid was used to assure equal spacing of the injections. All trials
compared the treatment group with a placebo injection group. The measured outcome that I have
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reviewed from the trials is patient satisfaction of their submental appearance. All three articles
were phase III, randomized, double-blind, placebo controlled clinical trials.
The key words used in searches were “ATX-101”, “Deoxycholic Acid”, and
“Submental fat”. All articles were published in English and were found on PubMed and
Cochrane databases. Inclusion criteria for my search were studies that were randomized,
controlled, and double blind. Exclusion criteria included individuals younger than 18, individuals
with minimal submental fat, and individuals who were already satisfied with their submental
appearance. The statistics used in the trials included NNT, CER, EER, ABI, and RBI.
Outcomes Measured
The outcome that was measured in all the studies that I focused on was the subject
self-satisfaction rating (SSRS). I chose this outcome because it directly relates to how the patient
felt about the treatment making it a POEM. The SSRS is a numeric scale from 0-6. The value of
0 was used for extremely dissatisfied, 1 for dissatisfied, 2 for slightly dissatisfied, 3 for neither
satisfied nor dissatisfied, 4 for slightly satisfied, 5 for satisfied, and 6 for extremely satisfied. In
these trials a person had to rate themselves 0-3 to be included. After treatment a value of 4-6 was
considered a success. The studies also followed adverse effects reported by the study
participants. The three most commonly reported adverse effects were bruising, anesthesia, and
pain. Patients reported when these effects were experienced after each treatment.
Results
The REFINE-1 study included 506 participants with 256 being randomized to the
treatment group and the other 200 to placebo injection. All 506 participants were included in the
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Table 1. Study Demographic

Study

Type

Ascher
(2013)

Double
Blind
RCT

6

Jones
(2015)
4

Rzany
(2013)
5

#
Pts
360

Age (yrs)

Inclusion Criteria

Exclusion Criteria

46±9.87

Men and non-pregnant, non-lactating
women under medical birth control if of
reproductive age were required to be 1865 years of age. Patients with moderate
to severe (2-3) submental fat according
to the clinician-reported submental fat
rating scale (CR-SMFRS) who were
dissatisfied (0-3 on the subject selfrating scale) with their submental
appearance were eligible.

Double
Blind
RCT

506

49.5±9.3

Men and women age of 18-65 years.
Patients with moderate to severe (2-3)
submental fat according to the clinicianreported submental fat rating scale (CRSMFRS) who were dissatisfied (0-3 on
the subject self-rating scale) with their
submental appearance were eligible.
Patients also need a BMI ≤40kg/m 2 and
had a stable body weight for ≥6 months

Double
blind
RCT

363

46.4±10.2
9

Men and women age of 18-65 years.
Patients with moderate to severe (2-3)
submental fat according to the clinicianreported submental fat rating scale (CRSMFRS) who were dissatisfied (0-3 on
the subject self-rating scale) with their
submental appearance were eligible.
Patients also need a BMI ≤30 kg/m 2 .

Individuals with a BMI >30kg/m 2 .
Indiviuals with any significant abnormality in
their clinical and laboratory evaluations.
Patients with any of the following: previous
submental fat treatments or recent aesthetic
facial treatments; loose skin or previous
trauma in the neck or chin area, prominent
platysmal bands, any cause of enlargement in
the submental area other than submental
fat;patients currently on or considering
starting a weight-reduction regimen, or
sensitive to any components of the study.
Subjects were excluded if they had excessive
skin laxity or allergy/ hypersensitivity to the
components of the study drug or topical/ local
anesthetics; received treatment previously for
submental fat or were treated in the neck/chin
area with radiofrequency, lasers, chemical
peels, or dermal fillers ≤12 months or
botulinum toxin injections ≤ 6 months before
randomization; or previously participated in
ATX-101 trials
Previous intervention to treat submental fat,
anatomical features or previous trauma;
evidence of any cause of submental
enlargement other than submental fat;.
Patients with a history of sensitivity to any
components of the study material or topical
or local anesthetics were also exclueded

W
/D
26

Interventions

0

A maximum of 10mL
of deoxycholic acid
injected with 0.2mL
injections injected
1.0cm apart using a
grid to provide even
coverage.

34

A maximum of 10mL
of deoxycholic acid
injected with 0.2mL
injections injected
1.0cm apart using a
grid to provide even
coverage.

A maximum of 10mL
of deoxycholic acid
injected with 0.2mL
injections injected
1.0cm apart using a
grid to provide even
coverage.
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final analysis. Using the SSRS as the measured variable, those in the treatment group had a
success rate of 82.8% compared to the placebo success rate of 31.0% (p-value<0.001). The NNT
for this trial was 3. This study used a maximum of 6 different treatments spaced out 28±5 days.
In the treatment group 164 individuals received all 6 treatments and 92 received less than six.
The three biggest reasons that were given for withdrawal were insufficient submental fat (33),
adverse effects (19), and withdrawal of consent due to subject convenience (14). In the control
group 213 received all 6 treatments and 37 received less than 6.1
Ascher et al had 360 patients in the study. 117 patients were randomized to the
placebo injection group. 122 were put into the treatment group with the concentration of
2.0mg/cm2. This is the concentration that was consistent throughout all of the trials; therefore it
was used for the purposes of this study. The treatment group had success on the SSRS with a rate
of 64.8% compared to a placebo success rate of 29.3% (p-value<0.001). The NNT in this study
was 3. This study looked at four treatment sessions spaced 28±5 days. In the injection group 32
of the 122 withdrew from the study early. The most common reasons were adverse effects (14),
consent withdrawn (10), and early success (6). 16 of the 117 in the placebo group withdrew from
the study early.2
The Rzany et al. study included 363 participants. There were 122 randomized to the
placebo group. Another 121 were placed in the treatment group that received the 2.0mg/cm2
concentration. 66.1% of the individuals in the treatment group were a success on the SSRS
compared to 28.7% in the placebo group (p-value <0.001). This study also had a maximum of 4
treatments spaced out 28±5 days. 34 of the 121 discontinued the treatment before receiving all
four treatments. The most common reason was early therapeutic success (13), followed by
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adverse effects (10), and withdrawal (7). 14 of the 122 participants in the placebo group
discontinued prematurely.3
Table 2. SSRS Results
Experimental
Control Event
Study

Numbers
Absolute Benefit

Relative Benefit

increase (ABI)

Increase (RBI)

Event Rate
Rate (CER)

Needed to Treat

(EER)

(NNT)

REFINE-11

31.0%

82.8%

167.1%

51.8%

2

Ascher et al2

29.3%

64.8%

121.1%

35.5%

3

Rzany et al3

28.7%

66.1%

130.3%

37.4%

3

Safety outcomes were recorded in each trial as adverse effects. The REFINE-1 study
used clinician visual and tactile assessments of the submental region, as well as reports of
adverse effects, laboratory tests (U/A, Chemistry, Hematology, and thyroid function, and vital
signs. The studies by Ascher et al and Rzany et al used clinical evaluations and patient reports of
adverse effects before and after each treatment to record safety outcomes. They also used
unspecified clinical laboratory parameters. The NNH for the most common adverse effects of
pain, bruising, and anesthesia are displayed in table 3.
Table 3. Adverse Effects
Study

Bruising NNH

Anesthesia NNH

Pain NNH

REFINE-11

37

2

2

Ascher2

10

2

2

Rzany3

7

2

2

Curry, Deoxycholic Acid Injections, 7

Discussion
The SSRS was chosen for this review because of its universal application in the
studies and because it answers a simple question “did you go from unsatisfied to satisfied with
the appearance of your submental region?” Using the SSRS all of the trials showed a statistically
significant increase in the treatment groups compared to placebo. For the purposes of this review
this variable was selected from all of the studies because it is patient oriented evidence that
provides insight into exactly how the patients felt about the treatment. However, all of the studies
had other outcomes that they measured. The other outcomes included a clinician evaluated
submental fat convexity and patient evaluated submental fat rating. They also followed the
psychological impact of submental fat appearance on feelings and perceived visual self-image
using a standardized reporting scale.
Deoxycholic acid is currently being used under the brand name Kybella distributed
by Kythera Biopharmaceuticals. This treatment is purely cosmetic and is an elective treatment;
therefore virtually no insurance covers the cost. The actual out of pocket cost for patients varies
due to the individualized nature of the treatment. Patients with more submental fat could require
more injections per treatment and more treatments overall which could inflate costs. The cost of
treatment varies between providers and also between geographic regions. It’s not unreasonable to
expect to spend several thousand dollars for all of the required treatments.
These trials all compared the deoxycholic acid injections to a placebo injection. A
more potent comparison could be made by comparing different forms of treatment such as
liposuction; however, this would have to be a comparison between two different subjects as one
person would not be eligible for both treatments.
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The adverse effects were also reported significantly more in the treatment group
compared to the control. All three trials however, reported that many of these effects were
experienced during their first treatment and faded quickly. There were instances of dysphagia
and facial paralysis reported by the trials, but they did not have a high enough incidence to be
reported in the results (needed incidence ≥5%). The authors also reported that these effects were
transient.
CONCLUSION
The trials all had a significant increase in SSRS in the treatment groups compared to
placebo. Therefore deoxycholic acid injections did decrease submental fat in a way to improve
satisfaction with the submental region. The comparison between these injections and other
modalities of reducing submental fullness has not been fully explored. Further research could be
conducted to show a superior treatment, if one exists. Currently there are studies that are being
done to evaluate the long term effectiveness of deoxycholic acid injections. Currently, however,
these injections seem to be an effective and relatively safe method of reducing submental fat in
individuals who wish to do so.

References
1. Jones DH, Carruthers J, Joseph JH, et al. REFINE-1, a multicenter, randomized, double-blind,
placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction.
Dermatol Surg. 2015. doi: 10.1097/DSS.0000000000000578 [doi].

2. Rzany B, Griffiths T, Walker P, Lippert S, McDiarmid J, Havlickova B. Reduction of unwanted
submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: Results from a
phase III, randomized, placebo-controlled study.2014;170(2):445-53. doi: 10.1111/bjd.12695.

3. Ascher B, Hoffmann K, Walker P, Lippert S, Wollina U, Havlickova B. Efficacy, patient-reported
outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of
unwanted submental fat: Results from a phase III, randomized, placebo-controlled
study.2013;28(12):1707-15. doi: 10.1111/jdv.12377.

4. ASDS survey: Half of consumers considering cosmetic procedure. American Society for
Dermatologic Surgery Web site.
http://www.asds.net/uploadedFiles/Doctor_Resources_NEW/Member_Center/Patient_and_Public_Educ
ation_Tools/2015%20Infographic_FINAL.pdf. Published August 4, 2015. Updated August 4, 2015.
Accessed October 6, 2016.

5. ISAPS international survey on Aesthetic/Cosmetic procedures performed in 2015. International
Society of Aesthetic Plastic Surgery Web site. http://www.isaps.org/Media/Default/globalstatistics/2016%20ISAPS%20Results.pdf. Published 2015. Updated 2015. Accessed October 6, 2016.

6. 2012 national average for Physician/Surgeon fees per procedure. American Society for Aesthetic
Plastic Surgery Web site. https://s3.amazonaws.com/asaps/assets/stats/2012/ASAPS-2012-Stats-pg16.pdf. Published 2012. Accessed October 6, 2016.

